EP Patent

EP3679016A4 — SOLID FORMS OF 2- (5- (4- (2-MORPHOLINOETHOXY) PHENYL) PYRIDIN-2-YL) -N-BENZYLACETAMIDE

Assigned to Atnx Spv LLC · Expires 2021-09-29 · 5y expired

What this patent protects

Patent listed against Klisyri.

Drugs covered by this patent

Patent Metadata

Patent number
EP3679016A4
Jurisdiction
EP
Classification
—
Expires
2021-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Atnx Spv LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.